The aim of the present study is to investigate the effects of the transdermal patch on the parameters of hemostasis (blood clotting), lipid (fat), and carbohydrate (sugars) metabolism in healthy women who require contraception.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
30
21-day regimen per cycle (1 patch a week for 3 weeks followed by a 7-day patch-free period) for 3 cycles
21-day regimen per cycle (1 tablet a day for 3 weeks followed by a 7-day tablet-free period) for 3 cycles
Unnamed facility
Berlin, State of Berlin, Germany
Prothrombin fragment 1+2, D-dimer
Time frame: Screening, visit 3-7
Procoagulatory parameters
Time frame: Screening, visit 3-7
Anticoagulatory parameters
Time frame: Screening, visit 3-7
Thrombin and Fibrin turnover parameters
Time frame: Screening, visit 3-7
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.